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Localization of the gene for 
Cowden disease to 
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Cowden disease (CD) (MIM 158350), or multiple 
hamartoma syndrome, is a rare autosomal domi­
nant familial cancer syndrome with a high risk of 
breast cancer. Its clinical features include a wide 
array of abnormalities but the main characteristics 
are hamartomas of the skin, breast, thyroid, oral 
mucosa and intestinal epithelium. The pathogno­
monic hamartomatous features of CD include 
multiple smooth facial papules, acral keratosis 
and multiple oral papillomas1*2. The pathological 
hallmark of the facial papules are multiple 
trichilemmomas3. Expression of the disease is 
variable and penetrance of the dermatological 
lesions is assumed to be virtually complete by the 
age of twenty4. Central nervous system manifes­
tations of CD were emphasized only recently and 
include megaiencephaly, epilepsy and dysplastic 
gangliocytomas of the cerebellum (Lhermitte- 
Duelos disease, LDD)5"7. Early diagnosis is impor­
tant since female patients with CD are at risk of 
developing breast cancer. Other lesions include 
benign and malignant disease of the thyroid, 
intestinal polyps and genitourinary abnormali- 
ties4>8~10. To localize the gene for CD, an autoso­
mal genome scan was performed. A total of 12 
families were examined, resulting in a maximum 
lod score of 8.92 at 0 = 0.02 with the marker 
D10S573 located on chromosome 10q22-23.
Twelve families participated in this study, including 
40 affected individuals. Since CD has clinical manifes­
tations similar to other phako mato ses such as ne uro fi- 
bromatosis and tuberous sclerosis, the initial search for 
linkage was concentrated on chromosomal regions 
known to contain tumour suppressor genes. We were
able to exclude all the candidate ______________
loci, including BRCAl, BRCA2 and 
the multiple endocrine neoplasia 
type 2 locus, RET,
Subsequently, a genome scan was 
initiated in five unrelated Dutch 
families: N l, N2, N3, N4 & N5.
Testing 300 markers resulted in the 
exclusion of 85% of the genome.
An indication of linkage (lod score 
>1) was obtained at four different 
loci; AMY2B (chromosome 1),
D3SI286, D10S573 and APOCII 
(chromosome 19). At two of these 
loci, the lod score exceeded 2
(D3S1286 and D10S573). Using additional markers 
and family 0014, three of these loci could be excluded. 
For the fourth region, located on the long arm of chro­
mosome 10, a statistically significant maximum lod 
score of 6.67 at 0 = 0.03 was obtained with marker 
D10S215. A more detailed analysis of this region was 
performed with the inclusion of seven additional fami­
lies. Eight markers, localized to 10q22-23 (ref. 11), 
showed significant evidence for linkage to CD (Table 
1). The highest lod scores were obtained with two 
markers: D10S573, Zmax=8.92 at 0 = 0.02 and 
D1QS215> = 8.19 at 0 = 0.02,max
Haplotypes were constructed to define the most 
likely position of the Cowden gene within this region. 
The critical recombinants occurred in individuals N4- 
11-10 and 0014-III-3, both of whom have features of 
CD (as defined in Methods). The most likely position 
of the Cowden gene is in a 5 cM region between 
D10S215 (N4-1M0) and D10S564 (0Ü14-II1-3) (Figs 1, 
2 and 3). The pattern of inheritance in all other fami­
lies is consistent with this localization.
In family N2, individual 11-11 inherited the unaf­
fected haplotype (Fig. 1). Based on our dermatological 
criteria, he initially was considered affected. However, 
his clinical symptoms include a borderline number of 
keratotic lesions on the forearm and a few non-charac­
teristic facial papules that were not examined patho­
logically. No other features of CD could be detected 
that, in contrast, are quite obvious in his affected rela­
tives. Furthermore, both his daughters III-9 and III- 
10, aged 32 and 28 respectively, are free of symptoms, 
although one of them received the reconstructed unaf­
fected grandmaternal chromosome. If, however, indi­
vidual N2-II-11 is considered affected, the maximum 
lod score is reduced to 7.14 at 0 = 0.04.
There is no indication for genetic heterogeneity 
among the 12 families who originated from four dif­
ferent countries, CD in all the families, including four 
with LDD, showed linkage to 10q22-23. Although the 
pathognomonic dermatological features of CD are 
almost invariant, there is large clinical variation 
among families. An obvious example would be the 
presence or absence of LDD in CD families. The even­
tual isolation of the gene would resolve some of these 
issues pertaining to gen otype~p heno type relation­
ships.
No tumour suppressor gene or oncogene has yet 
been identified in the Cowden critical region. The 
presence of tumour suppressor genes on chromosome 
10 has been indicated by loss of heterozygosity (LOH)
Table 1 Two-point lod scores between the 
CD locus and CA repeats markers
Lod score (chromosome 10q22-23)
Iocus/0 0.00 0.05 0.10 0.20 0.30 0.40 ®max L°dmax
D10S580 “ 18.33 0.01 0.87 1.11 0.73 0.23 0.17 1.15
D10S605 -5.99 1.80 2.09 1.83 1.14 0.37 0.11 2.11
D10S569 -8.34 0.62 1.15 1.18 0.75 0.23 0.15 1.26
D10S607 —1.34 2.78 2.58 1.85 1.00 0.24 0.04 2.79
D103219 3.26 7.02 6.41 4.73 2.81 0.96 0.03 7.14
D10S201 -5.96 2.83 2.96 2.42 1.44 0.43 0.09 2.98
D10S573 5.19 8.63 7.77 5.61 3.24 1.03 0.02 8.92
D10S215 4.40 7.99 7.24 5.30 3.09 0.97 0,02 8.19
D10S564 2.34 5.12 4.75 3.56 2.11 0.67 0.04 5.15
D10S583 -4.62 3,59 3.59 2.83 1.72 0.59 0.07 3.65
D10S574 -0.09 4.60 4.37 3.36 2.01 0.63 0.05 4.60
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Fig. 1 Pedigrees of three Cowden disease families, 
Haplotypes of persons available for this study are 
shown. Bars indicate the chromosome and show 
regions of crossover. The mutation-carrying chromo­
some is depicted in black. Markers used to form this 
haplotype (proximal-distal): D10S580, D10S219, 
D10S573, D10S215, D10S564 and D10S583.
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in different types of tumours. Studies in follicular thy­
roid and uterine tumours, all components of CD, have 
shown frequent LOH on lOq (refs 12,13). The region 
of LOH was determined with more detail in endome­
trial tumours and the Cowden critical region may par­
tially overlap this region14.
There are several known genes mapped to the 
10q22-23 region: ACTA2> Giudi, INFÏ56 and ZNF32 
(GDB). Apart from ZNF32, the genes mentioned are 
not strong candidate genes. ZNF32 is a member of the 
family ZNF KOX genes which encode the C2H2 Krüp­
pel type (Class I) of zinc finger proteins15. There are at 
least two examples of inherited syndromes with devel­
opmental defects which are known to result from 
germline mutations in ZNF  genes. The first is the GLÏ3 
gene in Greig cephalopolydactyly syndrome16 and the
multipoint lod score
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Fig, 2 Multipoint calculation. Markers used are flanking the Cowden critical region.
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second is the W Tl tumour suppres­
sor gene in Denys-Drash syn­
drome17,18. In addition, other 
ZNF-type proteins bind DNA at 
promoter sites and probably play 
important roles in gene regula­
tion19-23. Fine mapping o f ZNF32 is 
necessary to determine if it maps 
within the Cowden critical region. 
The two most severe complica­
tions for CD are neurological and 
neoplastic. There is insufficient 
inform ation whether m egalen- 
cephaly is caused by hypermyeli- 
nation or by increased cerebral 
cellularity. Both hypermyelination 
and hypercellulairity are features 
consistent with the possibility that 
the Cowden gene might be a 
tumour suppressor gene. From an 
oncologic point o f view, we suspect 
the CD gene might play a role in 
both familial and sporadic breast cancer and in famil­
ial thyroid syndromes. The high frequency of breast 
cancer in female Cowden patients (30%)4,8“10 makes it 
a strong candidate gene for a new breast cancer suscep­
tibility gene. In addition, its candidacy for the locus of 
noil-medullary thyroid cancer should be considered. 
From this study, DNA-based predictive testing for CD 
in informative families is now possible, allowing early
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Fig. 3 Chromosomal localization of the Cowden critical region. 
Recombinant 0014-III-3, N2-III-4 and N4-II-10 are shown. 
Hatched circles indicate the affected haplotype, open circles 
indicate the unaffected haplotype. The Cowden Critical region is 
depicted as a black bar.
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diagnosis and institution of possible early screening, 
such as for breast cancer.
Methods
Patients. Families Nl, N2, N4, N5, 0014 and D have been 
described4,5,7,24. Family N3 was ascertained becausc the 
proband was diagnosed on clinical grounds to have LDD. The 
neurological and oncologic features of these families will be 
reported elsewhere in detail (Peeters et al. and Lin et al., manu­
scripts in preparation). In addition, family D was ascertained 
because of LDD in the proband’s grandfather7. For the linkage 
studies we used the operational criteria formulated by the 
international CD consortium.
International Cowden Consortium CD diagnosis criteria.
Pathognomonic criteria for the diagnosis of Cowden disease 
include facial trichilemmomas, acral keratoses, papillomatous 
lesions and mucosal lesions. Breast cancer, thyroid cancer 
(especially PTC type), macrocephaly (97th percenile) and LDD 
were considered major criteria. Thyroid lesions (goitre), men­
tal retardation (IQ < 75), gastrointestinal hamartomas, fibro­
cystic disease of the breast, lipomas, fibromas and 
genitourinary tumours or malformations were applied as 
minor criteria. For the diagnosis of an individual the mucocu- 
tanous lesions are diagnostic if there are six or more papules, 
of which three or more must be trichillemmomas. Also cuta­
neous facial papules and oral mucosal papillomatosis, or oral 
mucosal papillomatosis and acral keratosis, or palmo plantar 
keratosis (> 6) are considered diagnostic for CD. Indicative cri­
teria for CD include: two major criteria where one is either 
LDD or macrocephaly; one major with three minor criteria; or 
four minor criteria. All patients fulfill these criteria.
Typing of DNA markers. Genomic DNA used for the typing of 
the DNA polymophisms was isolated as described25. Amplifi­
cation of the polymorphic regions and the separations of the 
amplified fragments was performed as described26,27.
Statistical evaluation. Lod scores were calculated using the 
Linkage program (version 5.1)28 subroutine MLINK for the 
two-point linkage. Multipoint calculations were done using 
FASTLINK (version 2.30), subroutine LINKMAP29. The gene 
frequency was estimated as 0.000001. Non-penetrance after the 
age of 20 was estimated to be 10%. Individuals above the age of
20 were typed and used for lod score calculation. For the indi­
vidual N2-II-11, the affection status was said to be unknown.
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